Home » FDA Panel Backs Lung Infection Drug
FDA Panel Backs Lung Infection Drug
Federal health advisers are recommending the use of an experimental Gilead Sciences drug to treat
a form of lung infection.
Concord Monitor
Concord Monitor
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May